Unique ID issued by UMIN | UMIN000016584 |
---|---|
Receipt number | R000019240 |
Scientific Title | Combination of revascularization surgery and double filtration plasmapheresis with thermo-recirculation (DF Thermo) for the treatment of peripheral arterial disease (ASO) |
Date of disclosure of the study information | 2015/02/20 |
Last modified on | 2017/12/23 15:23:11 |
Combination of revascularization surgery and double filtration plasmapheresis with thermo-recirculation (DF Thermo) for the treatment of peripheral arterial disease (ASO)
Combination of revascularization surgery and double filtration plasmapheresis with thermo-recirculation (DF Thermo) for the treatment of peripheral arterial disease (ASO)
Combination of revascularization surgery and double filtration plasmapheresis with thermo-recirculation (DF Thermo) for the treatment of peripheral arterial disease (ASO)
Combination of revascularization surgery and double filtration plasmapheresis with thermo-recirculation (DF Thermo) for the treatment of peripheral arterial disease (ASO)
Japan |
Peripheral arterial disease with wound and/or ulcer in the lower limb
Plastic surgery |
Others
NO
To evaluate the efficacy of DF Thermo therapy in the severe ischemic limb ASO patients who underwent bypass revascularization surgery, and with wound and/or ulcer in the lower limb.
Efficacy
Rate of diminishment of wound and/or ulcer by DF thermo therapy
SPP, ABI, ultrasonography of lower limb, VEGF, fibrinogen, IgM, LDL-cholesterol, HDL-cholesterol, total cholesterol, DESIGN-R, Vascu QOL
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Device,equipment |
DF Thermo group (Patients underwent DF Thermo therapy)
Study period; 35 weeks at the maximum
20 | years-old | <= |
86 | years-old | > |
Male and Female
Patients who fulfill all of the following conditions are included.
1) Age is over 20 years and less than 86 years, regardless of sex
2) Diagnosed as ASO with Fontaine Grade IV
3) With wound and/or ulcer in the lower limb and underwent bypass revascularization surgery
4) Patients who can give written informed consent by themselves or by their surrogates, understanding the objective and content of the study
Patients who fulfill any of the following conditions are excluded.
1) Pregnancy, breast-feeding, with possibility of pregnancy, or who wish to become pregnant during the study period
2) Patients who are considered as inadequate by the physician in charge
12
1st name | |
Middle name | |
Last name | Shinji Togashi |
Shonai Amarume Hospital
Plastic and reconstructive surgery
1-1-1 Shoyo, Shonai-town, Hogashitagawa, Yamagata
0234-43-3434
stoga@amarume-hp.jp
1st name | |
Middle name | |
Last name | Shinji Togashi |
Shonai Amarume Hospital
Plastic and reconstructive surgery
1-1-1 Shoyo, Shonai-town, Hogashitagawa, Yamagata
0234-43-3434
stoga@amarume-hp.jp
Shonai Amarume Hospital
Kawasumi Laboratories, Inc.
Profit organization
NO
2015 | Year | 02 | Month | 20 | Day |
Unpublished
Terminated
2015 | Year | 01 | Month | 05 | Day |
2015 | Year | 02 | Month | 25 | Day |
2015 | Year | 02 | Month | 19 | Day |
2017 | Year | 12 | Month | 23 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019240